360 related articles for article (PubMed ID: 14572381)
1. [Antifungal susceptibility of Candida spp. isolates from blood cultures in a five-year period (1997-2001)].
Durán MT; Velasco D; Canle D; Moure R; Villanueva R
Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):488-92. PubMed ID: 14572381
[TBL] [Abstract][Full Text] [Related]
2. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant Group.
Pfaller MA; Jones RN; Doern GV; Sader HS; Hollis RJ; Messer SA
J Clin Microbiol; 1998 Jul; 36(7):1886-9. PubMed ID: 9650930
[TBL] [Abstract][Full Text] [Related]
3. Antifungal susceptibility pattern of non-albicans Candida species & distribution of species isolated from Candidaemia cases over a 5 year period.
Chakrabarti A; Ghosh A; Batra R; Kaushal A; Roy P; Singh H
Indian J Med Res; 1996 Aug; 104():171-6. PubMed ID: 8840655
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
Martín E; Parras P; Lozano MC
Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
[TBL] [Abstract][Full Text] [Related]
5. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program.
Hajjeh RA; Sofair AN; Harrison LH; Lyon GM; Arthington-Skaggs BA; Mirza SA; Phelan M; Morgan J; Lee-Yang W; Ciblak MA; Benjamin LE; Sanza LT; Huie S; Yeo SF; Brandt ME; Warnock DW
J Clin Microbiol; 2004 Apr; 42(4):1519-27. PubMed ID: 15070998
[TBL] [Abstract][Full Text] [Related]
6. Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates.
Pfaller MA; Messer SA; Bolmström A; Odds FC; Rex JH
J Clin Microbiol; 1996 Jul; 34(7):1691-3. PubMed ID: 8784571
[TBL] [Abstract][Full Text] [Related]
7. Fungemia in the French department of Mayotte, Indian Ocean: A 10 years survey.
Wankap R; Mogo C; Niang M; Diallo A; Balloy L; Baes L; Collet L; Benoit-Cattin T; Permal S; Guegan H; Gangneux JP
J Mycol Med; 2021 Mar; 31(1):101081. PubMed ID: 33360730
[TBL] [Abstract][Full Text] [Related]
8. Eight-year surveillance of non-albicans Candida spp. in an oncology department prior to and after fluconazole had been introduced into antifungal prophylaxis.
Kunova A; Trupl J; Demitrovicova A; Jesenska Z; Grausova S; Grey E; Pichna P; Kralovicova K; Sorkovska D; Krupova I; Spanik S; Studena M; Koren P; Krcmery V
Microb Drug Resist; 1997; 3(3):283-7. PubMed ID: 9271000
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility of 545 isolates of Candida spp. to four antifungal agents.
Arias A; Arévalo MP; Andreu A; Rodríguez C; Sierra A
Mycoses; 1994; 37(7-8):285-9. PubMed ID: 7739661
[TBL] [Abstract][Full Text] [Related]
10. Changing trends in epidemiology and antifungal susceptibility patterns of six bloodstream Candida species isolates over a 12-year period in Kuwait.
Khan Z; Ahmad S; Al-Sweih N; Mokaddas E; Al-Banwan K; Alfouzan W; Al-Obaid I; Al-Obaid K; Asadzadeh M; Jeragh A; Joseph L; Varghese S; Vayalil S; Al-Musallam O
PLoS One; 2019; 14(5):e0216250. PubMed ID: 31042770
[TBL] [Abstract][Full Text] [Related]
11. Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
Lindberg E; Hammarström H; Ataollahy N; Kondori N
Sci Rep; 2019 Mar; 9(1):3838. PubMed ID: 30846717
[TBL] [Abstract][Full Text] [Related]
12. Yeasts from blood cultures in the wake of the COVID-19 pandemic in a tertiary care hospital: Shift in species epidemiology, steady low antifungal resistance and full in vitro ibrexafungerp activity.
Díaz-García J; Mesquida A; Machado M; Sánchez-Carrillo C; Muñoz P; Escribano P; Guinea J
Med Mycol; 2023 Jul; 61(7):. PubMed ID: 37460168
[TBL] [Abstract][Full Text] [Related]
13. Species distribution and antifungal susceptibility profile of Candida isolates from blood and other normally sterile foci from pediatric ICU patients in Tehran, Iran.
Mirhendi H; Charsizadeh A; Eshaghi H; Nikmanesh B; Arendrup MC
Med Mycol; 2020 Feb; 58(2):201-206. PubMed ID: 31111910
[TBL] [Abstract][Full Text] [Related]
14. Prospective, multicenter surveillance study of Candida glabrata: fluconazole and itraconazole susceptibility profiles in bloodstream, invasive, and colonizing strains and differences between isolates from three urban teaching hospitals in New York City (Candida Susceptibility Trends Study, 1998 to 1999).
Safdar A; Chaturvedi V; Koll BS; Larone DH; Perlin DS; Armstrong D
Antimicrob Agents Chemother; 2002 Oct; 46(10):3268-72. PubMed ID: 12234857
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003.
Almirante B; Rodríguez D; Park BJ; Cuenca-Estrella M; Planes AM; Almela M; Mensa J; Sanchez F; Ayats J; Gimenez M; Saballs P; Fridkin SK; Morgan J; Rodriguez-Tudela JL; Warnock DW; Pahissa A;
J Clin Microbiol; 2005 Apr; 43(4):1829-35. PubMed ID: 15815004
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers.
Colombo AL; Nucci M; Park BJ; Nouér SA; Arthington-Skaggs B; da Matta DA; Warnock D; Morgan J;
J Clin Microbiol; 2006 Aug; 44(8):2816-23. PubMed ID: 16891497
[TBL] [Abstract][Full Text] [Related]
17. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998.
Pfaller MA; Jones RN; Doern GV; Sader HS; Messer SA; Houston A; Coffman S; Hollis RJ
Antimicrob Agents Chemother; 2000 Mar; 44(3):747-51. PubMed ID: 10681349
[TBL] [Abstract][Full Text] [Related]
18. Antifungal susceptibility trend and analysis of resistance mechanism for Candida species isolated from bloodstream at a Japanese university hospital.
Sakagami T; Kawano T; Yamashita K; Yamada E; Fujino N; Kaeriyama M; Fukuda Y; Nomura N; Mitsuyama J; Suematsu H; Watanabe H; Asai N; Koizumi Y; Yamagishi Y; Mikamo H
J Infect Chemother; 2019 Jan; 25(1):34-40. PubMed ID: 30401513
[TBL] [Abstract][Full Text] [Related]
19. Distribution, trends, and antifungal susceptibility of Candida species causing candidemia in Japan, 2010-2019: A retrospective observational study based on national surveillance data.
Kajihara T; Yahara K; Nagi M; Kitamura N; Hirabayashi A; Hosaka Y; Abe M; Miyazaki Y; Sugai M
Med Mycol; 2022 Sep; 60(9):. PubMed ID: 36095139
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological trends in nosocomial candidemia in intensive care.
Bassetti M; Righi E; Costa A; Fasce R; Molinari MP; Rosso R; Pallavicini FB; Viscoli C
BMC Infect Dis; 2006 Feb; 6():21. PubMed ID: 16472387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
